Original Approach for Automated Quantification of Antinuclear Autoantibodies by Indirect Immunofluorescence

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td align="left"> </td><td align="center">ICARE+</td><td align="center">ICARE−</td><td align="center">Total</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td align="left">Visual+ </td><td align="center">127</td><td align="center">7</td><td align="center">134</td></tr><tr><td align="left">Visual−</td><td align="center">2</td><td align="center">101</td><td align="center">103</td></tr><tr><td align="left" colspan="4"><hr/></td></tr><tr><td align="left">Total</td><td align="center">129</td><td align="center">108</td><td align="center">237</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

ANA screening agreement between visual and ICARE evaluations.

Journal of Immunology Research

tab3

Table 3

Table 3: Original Approach for Automated Quantification of Antinuclear Autoantibodies by Indirect Immunofluorescence 